SUELLEN TURNER: Open Payments
NPI 1275758203 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 27 payments from 13 companies in 2025. Trend: 2023 $976 · 2024 $562 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| ABBVIE INC. | 4 | $79 |
| Novo Nordisk Inc | 4 | $75 |
| PFIZER INC. | 3 | $59 |
| Lilly USA, LLC | 2 | $38 |
| Amgen Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Edwards Lifesciences Corporation | 1 | $20 |
Products named: AIRSUPRA, UBRELVY, NURTEC ODT, MOUNJARO, SHINGRIX, OPSUMIT, Auvelity, EVENITY.
Industry payments across VA — which companies pay providers there.
